The Crucial Role Of Biomarker Research
The biomarker research includes the analysis of pharmacogenomics. Pharmacogenomics is a science studying the reaction of genes to drugs and it is being used to develop better medicinal drugs, and also for providing better health care. It also analyses DNA, RNA and biomolecules, measuring the different aspects of providing clients with the best health care available. The processes of the study range from the first phase of developing the drug, discovering it, and to making the evaluations and post marketing studies.
In order for the analysis to progress greatly, the sample sizes must be adequate, and there must be a high quality data information available for the scientists. Those samples give the researches the ability to interact with drugs, drug classes, and diseases. These clinical programmes give the researches the opportunity to conduct a productive analysis of the human body. The pharmaceutical companies are also contributing towards these studies by pooling the samples and expertises, in order to obtain a great result from the studies.
These biomarker researches conducted in the clinical trials are formed from a flow chart, and have seven different levels. First of all, the students agree to a procedure and sign it. Next step involves the biological samples being collected from the participants and their examination by the scientists in the laboratory.
Fourth step involves these results to be examined by using high-end tools such as statistical tools and so on. These analyzed drugs lead to a better development of drugs and treatment for diseases. With another consent, the samples are being stored in the laboratory for future biomarker research. Once science advances, the researchers are able to use the already stored samples in order to test for improvements of drugs for cancer metastasis.
There is only a small amount of risks when it comes to the collection of samples. These are principally related to privacy concerns and the means of obtaining samples. These physical risks of collecting the samples can be easily characterized in three ways. First off is the negligible risk of the sample being collected in order to support the core process. Second risk involves the procedure not being used as a core process right after the trial. The final risk involves the means of the sample collection method.
The privacy risks however are associated with data misuse and the inappropriate disclosure of the data to third parties. The pharmaceutical companies have different policies or procedures in order to protect the confidentiality and to protect the clients. The procedures vary from a company to another, but they all follow the same industry standards of protection.
The samples collected do not benefit the participant of the tests alone, but it benefits the whole human race. By submitting blood samples, participants help with the research of treatments for patients, and with understanding different diseases. The patients as of now benefit greatly from the analysis conducted on the already harvested samples from the previous clinical trials.
Once the medical science progresses even more, the biomarker research that has been conducted in the past will determine a major role when it comes to cures and treatments for diseases. The samples already stored will help the future generation even more. Therefore, it is a great tool when it comes to saving lives and helping the medics provide better health care for patients.


